The U.S. Food and Drug Administration’s outside vaccine advisers have voted unanimously to authorize Moderna’s COVID-19 vaccine for children between six months and five years of age.
They will vote separately on Pfizer’s vaccine submission for young children later Wednesday afternoon.
Young children are the only group that has remained ineligible for immunization during the pandemic.
Health Canada is also reviewing Moderna’s COVID-19 vaccine for younger children. Canada has not yet received an application for that age group from Pfizer. There is no word yet when a decision will be made in Canada.
More to come …
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/health/fda-covid-19-vaccines-young-kids-moderna-pfizer-1.6489885?cmp=rss.